Key Insights

Highlights

Success Rate

78% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

15.4%

2 terminated out of 13 trials

Success Rate

77.8%

-8.7% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed with results

Key Signals

78% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Early P 1 (1)

Trial Status

Completed7
Recruiting3
Terminated2
Withdrawn1

Trial Success Rate

77.8%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (13)

Research Network

Activity Timeline